Trial Profile
Pilot Study of Hepatic Arterial Infusion (HAI) With Oxaliplatin, Folinic Acid and 5 Fluorouracil (FOLFOX) in Heavily Pre-Treated Patients With Liver-Predominant Metastasis From Breast Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Breast cancer; Liver metastases
- Focus Therapeutic Use
- 02 Mar 2015 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
- 10 Sep 2013 New trial record